Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Acosta

Showing results (231-240 of 338) with videos related to

Pageof 34
Sort By:
AIDS (London, England)|January 26, 2018
Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIVNikki Mulligan, Brookie M Best, Jiajia Wang, et al.
The European Respiratory Journal|February 19, 2026
Impact of CFTR Modulator Concentrations on Clinical Response in Cystic FibrosisAshritha R Chalamalla, Elizabeth Baker, Kevin J Ryan, et al.
AIDS (London, England)|April 15, 2015
Impact of protease inhibitors on intracellular concentration of tenofovir-diphosphate among HIV-1 infected patientsCecile D Lahiri, Sijia Tao, Yong Jiang, et al.
AIDS (London, England)|May 20, 2024
Bridging dolutegravir clinical viral response across doses and formulations using model-based exposure-response analysis in pediatricsHardik Chandasana, Siobhán Hayes, Ann M Buchanan, et al.
Clinical Pharmacology and Therapeutics|May 29, 2014
The posology of oseltamivir in infants with influenza infection using a population pharmacokinetic approachM A Kamal, E P Acosta, D W Kimberlin, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2007
Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice dailyEdward P Acosta, Michelle A Kendall, John G Gerber, et al.
AIDS (London, England)|November 21, 2009
A cluster-randomized trial of enhanced labor ward-based PMTCT services to increase nevirapine coverage in Lusaka, ZambiaKaren M Megazzini, Moses Sinkala, Sten H Vermund, et al.
The Journal of Infectious Diseases|July 23, 2002
The pharmacokinetics of amprenavir, zidovudine, and lamivudine in the genital tracts of men infected with human immunodeficiency virus type 1 (AIDS clinical trials group study 850)Arlene S Pereira, Laura M Smeaton, John G Gerber, et al.
Journal of Clinical Pharmacology|March 11, 2015
Population pharmacokinetic analysis of raltegravir pediatric formulations in HIV-infected children 4 weeks to 18 years of ageMatthew L Rizk, Lihong Du, Chantelle Bennetto-Hood, et al.
Plos Neglected Tropical Diseases|April 16, 2021
Effect of maternal praziquantel treatment for Schistosoma japonicum infection on the offspring susceptibility and immunologic response to infection at age six, a cohort studySusannah Colt, Blanca Jarilla, Palmera Baltazar, et al.
Pageof 34

Showing results (231-240 of 338) with videos related to

Sort By:
Pageof 34
AIDS (London, England)|January 26, 2018
Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIVNikki Mulligan, Brookie M Best, Jiajia Wang, et al.
The European Respiratory Journal|February 19, 2026
Impact of CFTR Modulator Concentrations on Clinical Response in Cystic FibrosisAshritha R Chalamalla, Elizabeth Baker, Kevin J Ryan, et al.
AIDS (London, England)|April 15, 2015
Impact of protease inhibitors on intracellular concentration of tenofovir-diphosphate among HIV-1 infected patientsCecile D Lahiri, Sijia Tao, Yong Jiang, et al.
AIDS (London, England)|May 20, 2024
Bridging dolutegravir clinical viral response across doses and formulations using model-based exposure-response analysis in pediatricsHardik Chandasana, Siobhán Hayes, Ann M Buchanan, et al.
Clinical Pharmacology and Therapeutics|May 29, 2014
The posology of oseltamivir in infants with influenza infection using a population pharmacokinetic approachM A Kamal, E P Acosta, D W Kimberlin, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2007
Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice dailyEdward P Acosta, Michelle A Kendall, John G Gerber, et al.
AIDS (London, England)|November 21, 2009
A cluster-randomized trial of enhanced labor ward-based PMTCT services to increase nevirapine coverage in Lusaka, ZambiaKaren M Megazzini, Moses Sinkala, Sten H Vermund, et al.
The Journal of Infectious Diseases|July 23, 2002
The pharmacokinetics of amprenavir, zidovudine, and lamivudine in the genital tracts of men infected with human immunodeficiency virus type 1 (AIDS clinical trials group study 850)Arlene S Pereira, Laura M Smeaton, John G Gerber, et al.
Journal of Clinical Pharmacology|March 11, 2015
Population pharmacokinetic analysis of raltegravir pediatric formulations in HIV-infected children 4 weeks to 18 years of ageMatthew L Rizk, Lihong Du, Chantelle Bennetto-Hood, et al.
Plos Neglected Tropical Diseases|April 16, 2021
Effect of maternal praziquantel treatment for Schistosoma japonicum infection on the offspring susceptibility and immunologic response to infection at age six, a cohort studySusannah Colt, Blanca Jarilla, Palmera Baltazar, et al.
Pageof 34